Not applicableStudy completedNCT02057029
What this trial is testing
Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer
Who this might be right for
Breast CancerEarly Stage Estrogen Receptor (ER) Positive Breast Cancer
Yale University 96